Clinical Trial Update: "Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"

View source ↗

Summary

The document indicates that an individual patient Expanded Access IND to treat Primary Lateral Sclerosis sponsored by Hope Biosciences Research Foundation is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lateral Sclerosis

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Primary Lateral Sclerosis, Adult, 1 | Status: NO_LONGER_AVAILABLE